📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: InnoMedica

1.1 - Company Overview

InnoMedica Logo

InnoMedica

Headquarter: Switzerland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of patented liposomal nanocarrier drug delivery technology enabling selective, localized transport of active agents to affected areas, improving efficacy and reducing side effects. Offers oncology TLD-1 (Doxorubicin to tumors) and neurology TLN-1 (GM1-Ganglioside across the blood-brain barrier), GMP in-house manufacturing, and a pipeline of liposomal formulations for established and new substances, including RNA or proteins.

Products and services

  • Nanocarrier Technology: Patented liposomal drug-delivery system that selectively transports active pharmaceutical agents to affected tissue and releases them locally, improving efficacy and reducing systemic side effects
  • TLD-1: Nanocarrier-based oncology assembly that conveys Doxorubicin to tumor sites, enhancing intratumoral accumulation while minimizing adverse effects for cancer treatment
  • TLN-1: BBB-penetrant neurology component that crosses the blood-brain barrier to deliver GM1-Ganglioside to the brain, providing targeted neuroprotective action

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to InnoMedica

Nanocyl Logo

Nanocyl

HQ: Belgium Website
  • Description: Provider of carbon nanotubes (CNTs) and formulated CNT products that improve ESD/electrical conductivity, mechanical reinforcement, thermal dissipation and eco-friendly fouling release. Products: NC7000 industrial multiwall CNTs; PLASTICYL CNT masterbatches in thermoplastics; AQUACYL waterborne dispersions for coatings and energy storage; ORGACYL solventborne dispersions; EPOCYL epoxy concentrates; THERMOCYL silicone-based flame retardant coatings.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nanocyl company profile →
Nanostellar Logo

Nanostellar

HQ: United States Website
  • Description: Provider of nano-engineered, precious-metals-containing catalyst materials for automotive and stationary power industries, improving emissions control and energy efficiency, reducing exhaust emissions, and enabling compliance with stringent diesel emissions requirements in Europe, the U.S., and Asia, with applications in the synthesis of chemicals and fuels.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nanostellar company profile →
Oxford Nanopore Logo

Oxford Nanopore

HQ: United Kingdom Website
  • Description: Provider of electronics-based nanopore DNA/RNA sequencing technology used in more than 80 countries for biological research, including large-scale human genomics, cancer research, and microbiology. Portfolio includes devices from portable to ultra-high throughput: MinION, GridION, PromethION, the Flongle adapter, forthcoming SmidgION mobile device, and VolTRAX for automated sample and library preparation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oxford Nanopore company profile →
Rolic Logo

Rolic

HQ: Switzerland Website
  • Description: Provider of commercial materials for LCD display and optical products, developing and marketing materials for LCD displays and optical products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rolic company profile →
Nanostone Water Logo

Nanostone Water

HQ: United States Website
  • Description: Provider of ceramic and polymeric membrane solutions for industrial process fluid and water treatment. Offers ceramic membrane technology with fouling resistance and high permeability for applications such as municipal drinking water, seawater desalination, municipal wastewater reuse, boiler feed water for power generation, and cooling tower blowdown treatment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nanostone Water company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for InnoMedica

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to InnoMedica

2.2 - Growth funds investing in similar companies to InnoMedica

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for InnoMedica

4.2 - Public trading comparable groups for InnoMedica

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to InnoMedica

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About InnoMedica

What does InnoMedica do?

InnoMedica is a provider of patented liposomal nanocarrier drug delivery technology enabling selective, localized transport of active agents to affected areas, improving efficacy and reducing side effects. Offers oncology TLD-1 (Doxorubicin to tumors) and neurology TLN-1 (GM1-Ganglioside across the blood-brain barrier), GMP in-house manufacturing, and a pipeline of liposomal formulations for established and new substances, including RNA or proteins.

Who are InnoMedica's competitors?

InnoMedica's competitors and similar companies include Nanocyl, Nanostellar, Oxford Nanopore, Rolic, and Nanostone Water.

Where is InnoMedica headquartered?

InnoMedica is headquartered in Switzerland.

How many employees does InnoMedica have?

InnoMedica has 1,000 employees 🔒.

When was InnoMedica founded?

InnoMedica was founded in 2010 🔒.

What sector and industry vertical is InnoMedica in?

InnoMedica is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for InnoMedica

Who are the top strategic acquirers in InnoMedica's sector and industry

Top strategic M&A buyers and acquirers in InnoMedica's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for InnoMedica?

Top strategic M&A buyers groups and sectors for InnoMedica include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in InnoMedica's sector and industry vertical

Which are the top PE firms investing in InnoMedica's sector and industry vertical?

Top PE firms investing in InnoMedica's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in InnoMedica's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in InnoMedica's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in InnoMedica's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to InnoMedica include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in InnoMedica's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for InnoMedica?

The key public trading comparables and valuation benchmarks for InnoMedica include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for InnoMedica for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for InnoMedica with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in InnoMedica's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for InnoMedica with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in InnoMedica's' sector and industry vertical?

Access recent funding rounds and capital raises in InnoMedica's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for InnoMedica

Launch login modal Launch register modal